Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes.
Wei-Han ChenYujia LiLanting YangJohn M AllenHui ShaoWilliam T DonahooLori BilleloXia HuElizabeth A ShenkmanJiang BianSteven M SmithSerena Jingchuan GuoPublished in: PloS one (2024)
This study uncovered substantial geographic variation and the racial disparities in initiating newer GLDs.